NCT00726323 · Interventional trial
A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)
Overall registry status Completed
Phase 2
Conditions Carcinoma, Renal Cell
Delaware Valley sites
- GSK Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory